Conference Paper Published research by Fluid Tech CTO Mark Denton · 2012

Fukushima Nuclear Crisis Recovery: A Modular Water Treatment System Deployed in Seven Weeks

A modular water-treatment system designed, procured, and running at Fukushima within seven weeks of the 11 March 2011 disaster.

Authors Mark S. Denton, Joshua L. Mertz, William D. Bostick Venue WM2012 · Paper 12489

Conference Paper

The scientist behind this work is Fluid Tech's Chief Technology Officer. Mark S. Denton led media technology at Kurion, Inc. during the Fukushima Daiichi response (the affiliation printed on the paper), and the isotope-specific media science documented here is the foundation of Fluid Tech's WTZ® and FHA products. The media and systems in this paper were Kurion's; Fluid Tech's current products are described under Ion Exchange Media. The summary below is for reference only; full details are in the cited paper. See Dr. Denton's full publication timeline →

01 Overview

This paper describes the rapid design, procurement, and deployment of a modular water-treatment system at the Fukushima site within seven weeks of the earthquake and tsunami. It covers the media selection, the modular vessel approach, and the logistics of standing up a treatment train under emergency conditions.

Summary written from the published abstract. It reproduces no proprietary data, methods, or results.

02 Why it matters

  • Speed with selectivity: the system worked because the media were already developed and characterized. Readiness is the lesson.
  • Modular by design: shielded, sluiceable modules are the same architecture Fluid Tech uses on fuel-basin and outage work today.
  • A defining credential: Dr. Denton is lead author on the paper that documents the deployment.

03 Citation

Mark S. Denton, Joshua L. Mertz, William D. Bostick. Fukushima Nuclear Crisis Recovery: A Modular Water Treatment System Deployed in Seven Weeks. (Paper 12489). WM2012 Conference, February 26 – March 1, 2012, Phoenix, AZ. Full text (WM Symposia archive)

04 Related

Publication, testing, or permitting by a government laboratory, contractor, or agency does not constitute endorsement of any commercial product.